Nordaid OÜ
Nordaid OÜ is a OÜ based in Tallinn, registry code 12082150, status: active. Main activity: Manufacture of basic pharmaceutical products. According to EMTA, turnover for Q3 2026 was €149 979 with 7 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 149 979 €above 45% of companiesindustry median 234 187 € · companies in the industry: 12
- Labour taxes per employee 3 943 €above 37% of companiesindustry median 4 573 € · companies in the industry: 12
- Revenue · 2025 980 817 €above 65% of companiesindustry median 48 003 € · companies in the industry: 19
- Net profit margin · 2025 20.4 %above 64% of companiesindustry median 9.8 % · companies in the industry: 15
Taxes and turnover
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 149 979 | — | 27 604 | 7 |
| Q2 2026 | 173 345 | 4 453 | 23 320 | 7 |
| Q1 2026 | 285 371 | 16 272 | 21 882 | 7 |
| Q4 2025 | 211 681 | 28 278 | 30 073 | 7 |
| Q3 2025 | 151 352 | 15 241 | 28 039 | 7 |
| Q2 2025 | 178 422 | 8 718 | 28 102 | 7 |
| Q1 2025 | 159 423 | 21 878 | 27 527 | 7 |
| Q4 2024 | 198 576 | 6 862 | 28 190 | 7 |
| Q3 2024 | 130 481 | 16 282 | 28 088 | 7 |
| Q2 2024 | 155 977 | 12 458 | 24 181 | 7 |
| Q1 2024 | 180 433 | 4 664 | 25 676 | 7 |
| Q4 2023 | 293 407 | 6 501 | 29 342 | 9 |
| Q3 2023 | 276 443 | 15 131 | 31 958 | 7 |
| Q2 2023 | 151 594 | 1 573 | 29 668 | 9 |
| Q1 2023 | 227 387 | — | 27 832 | 9 |
| Q4 2022 | 200 062 | — | 24 314 | 9 |
| Q3 2022 | 117 872 | 754 | 25 031 | 9 |
| Q2 2022 | 275 480 | — | 23 084 | 9 |
| Q1 2022 | 273 317 | — | 20 349 | 9 |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 980 817 | 199 988 | 255 990 | 1 059 226 | 653 903 | 7 |
| 2024 | 978 239 | 64 073 | 256 120 | 1 039 557 | 453 915 | 7 |
| 2023 | 951 047 | 20 131 | 284 560 | 1 187 689 | 389 842 | 9 |
| 2022 | 856 338 | 106 491 | 236 350 | 843 022 | 369 711 | 9 |
| 2021 | 1 134 562 | 39 441 | 114 821 | 389 462 | 263 220 | 5 |
| 2020 | 781 936 | 178 845 | 40 407 | 417 042 | 223 779 | 1 |
| 2019 | 312 824 | 23 508 | 15 461 | 149 822 | 44 934 | 1 |
| 2018 | — | — | — | — | — | 0 |
| 2017 | — | — | — | — | — | 0 |
| 2016 | — | — | — | — | — | 0 |
| 2015 | — | — | — | — | — | 0 |
| 2014 | — | — | — | — | — | 0 |
| 2013 | — | — | — | — | — | 0 |
| 2012 | — | — | — | — | — | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 11 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 29 May 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 14 Jun 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 10 Mar 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 30 Jun 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 24 Jun 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 27 Oct 2020 | Company’s own | e-Äriregister |
Commercial pledges
| No. | Amount | Pledgee | Period |
|---|---|---|---|
| 1 | 416 000 € | Swedbank AS | 30 Dec 2021 – in force |
Board
- Kalle KõreBoard member · since 26 Nov 2019
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Kalle KõreNatural person · 1 285 €
- OÜ CallimachusLegal person · 11303301 · 1 235 €
Beneficial owners
- Kalle KõreDirect ownership · since 30 Oct 2018
Founders and other persons
No other persons.
Related companies
Activities (EMTAK)
- 21101Manufacture of basic pharmaceutical products Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10154497 / 18 2 Sep 2023 |
Amendment entry | In force 2 Sep 2023 |
||
| Ä 10154497 / 17 2 Aug 2022 |
Amendment under Commercial Code § 525 (2) | In force 2 Aug 2022 |
||
| Ä 10154497 / 16 11 Jan 2022 |
Amendment entry | In force 11 Jan 2022 |
||
| K 10154497 / 15 30 Dec 2021 |
Commercial pledge entered | In force 30 Dec 2021 |
||
| Ä 10154497 / 14 7 May 2021 |
Amendment under Commercial Code § 525 (2) | In force 7 May 2021 |
||
| Ä 10154497 / 13 26 Nov 2019 |
Amendment entry | In force 26 Nov 2019 |
||
| Ä 10154497 / 12 14 Mar 2019 |
Amendment entry | In force 14 Mar 2019 |
||
| Ä 10154497 / 11 20 Apr 2018 |
Amendment entry | In force 20 Apr 2018 |
||
| Ä 10154497 / M4 19 Apr 2018 |
Ruling to eliminate deficiencies | 29 Apr 2018 | Deficiencies eliminated 19 Apr 2018 |
|
| Ä 10154497 / 10 17 Jan 2018 |
Amendment entry | In force 17 Jan 2018 |
||
| Ä 10154497 / 9 2 Dec 2017 |
Amendment entry | In force 2 Dec 2017 |
||
| Ä 10154497 / 8 9 Oct 2017 |
Amendment entry | In force 9 Oct 2017 |
||
| Ä 10154497 / M3 2 Oct 2017 |
Ruling to eliminate deficiencies | 12 Oct 2017 | Deficiencies eliminated 9 Oct 2017 |
|
| Ä 10154497 / 7 14 Sep 2016 |
Amendment entry | In force 14 Sep 2016 |
||
| Ä 10154497 / 6 18 Mar 2015 |
Amendment entry | In force 18 Mar 2015 |
||
| Ä 10154497 / 5 26 Nov 2014 |
Amendment entry | In force 26 Nov 2014 |
||
| Ä 10154497 / M2 24 Oct 2014 |
Ruling to eliminate deficiencies | 23 Nov 2014 | Deficiencies eliminated 26 Nov 2014 |
|
| Ä 10154497 / 4 8 Dec 2011 |
Amendment entry | In force 8 Dec 2011 |
||
| Ä 10154497 / M1 28 Nov 2011 |
Ruling to eliminate deficiencies | In force 28 Nov 2011 |
||
| Ä 10154497 / 3 1 Nov 2011 |
Note on closing the former card of a transformed company | In force 1 Nov 2011 |
||
| Ä 10154497 / 2 1 Nov 2011 |
Transformation entry | In force 1 Nov 2011 |
||
| Ä 10154497 29 Mar 2011 |
First entry | In force 29 Mar 2011 |
Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data